Your browser doesn't support javascript.
loading
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report.
Dominguez-Valentin, Mev; Seppälä, Toni T; Sampson, Julian R; Macrae, Finlay; Winship, Ingrid; Evans, D Gareth; Scott, Rodney J; Burn, John; Möslein, Gabriela; Bernstein, Inge; Pylvänäinen, Kirsi; Renkonen-Sinisalo, Laura; Lepistö, Anna; Lindblom, Annika; Plazzer, John-Paul; Tjandra, Douglas; Thomas, Huw; Green, Kate; Lalloo, Fiona; Crosbie, Emma J; Hill, James; Capella, Gabriel; Pineda, Marta; Navarro, Matilde; Vidal, Joan Brunet; Rønlund, Karina; Nielsen, Randi Thyregaard; Yilmaz, Mette; Elvang, Louise Laurberg; Katz, Lior; Nielsen, Maartje; Ten Broeke, Sanne W; Nakken, Sigve; Hovig, Eivind; Sunde, Lone; Kloor, Matthias; Knebel Doeberitz, Magnus V; Ahadova, Aysel; Lindor, Noralane; Steinke-Lange, Verena; Holinski-Feder, Elke; Mecklin, Jukka-Pekka; Møller, Pål.
Afiliação
  • Dominguez-Valentin M; 1Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Seppälä TT; 2Department of Gastrointestinal Surgery, Helsinki University Central Hospital, Helsinki, Finland.
  • Sampson JR; 3Clinicum, University of Helsinki, Helsinki, Finland.
  • Macrae F; 4Division of Cancer and Genetics, Institute of Medical Genetics, Cardiff University School of Medicine, Cardiff, UK.
  • Winship I; 5The Royal Melbourne Hospital, Melbourne, Australia.
  • Evans DG; 6University of Melbourne, Melbourne, Australia.
  • Scott RJ; 5The Royal Melbourne Hospital, Melbourne, Australia.
  • Burn J; 6University of Melbourne, Melbourne, Australia.
  • Möslein G; 7University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK.
  • Bernstein I; University of Newcastle and the Hunter Medical Research Institute, Callaghan, Australia.
  • Pylvänäinen K; 9University of Newcastle, Newcastle upon Tyne, UK.
  • Renkonen-Sinisalo L; 10University Witten-Herdecke, Wuppertal, Germany.
  • Lepistö A; 11Department of Surgical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark.
  • Lindblom A; 12Central Finland Central Hospital, Education and Research, Jyväskylä, Finland.
  • Plazzer JP; 2Department of Gastrointestinal Surgery, Helsinki University Central Hospital, Helsinki, Finland.
  • Tjandra D; 13Research Programs Unit, Genome-Scale Biology, University of Helsinki, Helsinki, Finland.
  • Thomas H; 2Department of Gastrointestinal Surgery, Helsinki University Central Hospital, Helsinki, Finland.
  • Green K; 13Research Programs Unit, Genome-Scale Biology, University of Helsinki, Helsinki, Finland.
  • Lalloo F; 14Karolinska Institutet, Stockholm, Sweden.
  • Crosbie EJ; 5The Royal Melbourne Hospital, Melbourne, Australia.
  • Hill J; 6University of Melbourne, Melbourne, Australia.
  • Capella G; 15St Mark's Hospital, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Pineda M; 7University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK.
  • Navarro M; 7University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK.
  • Vidal JB; 16University of Manchester and St Mary's Hospital, Manchester, UK.
  • Rønlund K; 7University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK.
  • Nielsen RT; 17Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Yilmaz M; 18Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Elvang LL; 17Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Katz L; 18Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Nielsen M; 17Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Ten Broeke SW; 18Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Nakken S; 17Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Hovig E; 18Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Sunde L; 19Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
  • Kloor M; 20Department of Surgery, Regional Hospital West Jutland, Egtved, Denmark.
  • Knebel Doeberitz MV; 21Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.
  • Ahadova A; 22Department of Pathology, Herlev Gentofte University Hospital, Herlev, Denmark.
  • Lindor N; 23High Risk and GI Cancer prevention Clinic, Gatro-Oncology Unit, The Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel.
  • Steinke-Lange V; 24Leids Universitair Medisch Centrum, Leiden, Netherlands.
  • Holinski-Feder E; 24Leids Universitair Medisch Centrum, Leiden, Netherlands.
  • Mecklin JP; 1Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Møller P; 1Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
Hered Cancer Clin Pract ; 17: 28, 2019.
Article em En | MEDLINE | ID: mdl-31636762
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article